MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with T

Tamsulosin + Dutasteride

Tamsulosin 400microgram / Dutasteride 500microgram capsules

Use with caution

Stability notes for Tamsulosin 400microgram / Dutasteride 500microgram capsules

Caution in handling by female operatives. Avoid handling leaking capsules. Should not be handled by pregnant women and women of childbearing potential.

Provenance

This compatibility recommendation is derived from Combodart 0.5mg/0.4mg capsules (GlaxoSmithKline UK Ltd).

Suppliers (12) of Tamsulosin 400microgram / Dutasteride 500microgram capsules
Combodart 0.5mg/0.4mg capsules (CST Pharma Ltd)
Combodart 0.5mg/0.4mg capsules (Recordati Pharmaceuticals Ltd)
Dutrozen 0.5mg/0.4mg capsules (Zentiva Pharma UK Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (A A H Pharmaceuticals Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Accord-UK Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Alliance Healthcare (Distribution) Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Aristo Pharma Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Glenmark Pharmaceuticals Europe Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Medical Valley Invest AB)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Medihealth (Northern) Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Milpharm Ltd)
Tamsulosin 400microgram / Dutasteride 500microgram capsules (Thornton & Ross Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.